The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEHP.L Share News (EHP)

  • There is currently no data for EHP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

River & Mercantile UK Micro Cap Beats Index, Says Epistem "Hidden Gem"

Fri, 22nd Jan 2016 09:59

LONDON (Alliance News) - River & Mercantile UK Micro Cap Investment Co Ltd said Friday that it had seen a total return on net asset value of 12.6% in its first ten months to end-September, outperforming its benchmark which saw a return of 7.8%.

Numis Smaller companies plus AIM (excluding investment companies) total return index is the company's benchmark index.

River & Mercantile UK Micro said its first ten months since listing on the London Stock Exchange's Main Market at the end of 2014 had been "highly satisfactory."

For the period the company hailed strong returns from Nationwide Accident Repair Services Ltd and Alkane Energy PLC.

Three holdings detracted more than 1%, River and Mercantile UK Micro said: Shanta Gold Ltd, Blur Group PLC and Epistem Holdings PLC. The company noted that biotechnology and medicine company Epistem was the "most frustrating holding of the portfolio", as it felt that with positive news flow Epistem should have been the "top positive contributor in the period."

"Epistem is the epitome of a hidden gem in plain sight within the micro cap universe," River & Mercantile UK Micro said.

The investment company proposed no dividend for the period. Its shares were down 1.2% at 116.64 early Friday.

By Hana Stewart-Smith; hanassmith@alliancenews.com; @HanaSSAllNews

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
25 Jul 2016 07:51

Epistem Changes Name To Genedrive To Better Reflect Company Focus

Read more
12 Jul 2016 16:31

CORRECT: DIRECTOR DEALINGS: Epistem Directors Take Part In Placing

Read more
12 Jul 2016 12:08

DIRECTOR DEALINGS: Epistem Holdings Directors Take Part In Placing

Read more
23 Jun 2016 07:13

Epistem Urges Shareholders To Back Placing As Cash Begins To Dwindle (ALLISS)

Read more
7 Jun 2016 08:42

Epistem Secures Cornerstone Investor For Planned Fundraising (ALLISS)

Read more
3 May 2016 07:11

Epistem Says Genedrive Human Genotyping Trial Completed Successfully

Read more
18 Apr 2016 08:59

Epistem Starts Full Indian Commercial Launch For Genedrive

Read more
31 Mar 2016 09:33

WINNERS & LOSERS SUMMARY: AO World Surges On Strong Fourth Quarter

Read more
31 Mar 2016 08:42

Epistem Loss Widens As Focus Remains On Product Launch

Read more
21 Mar 2016 15:37

US DoD awards another £2m for Epistem biohazard project

(ShareCast News) - Epistem Holdings was gearing up for the next stage of its development programme with the US Department of Defense on Monday, having been awarded funding to proceed. The AIM-traded company received $2.4m (£1.7m) for the first phase of the $7.8m programme in August last year, to dev

Read more
21 Mar 2016 08:50

Epistem Gets USD2.9 Million Funding For Biohazard Identification Test

Read more
18 Feb 2016 08:00

Epistem Says First Test On Hepatitis C Test Completed Successfully

Read more
13 Jan 2016 09:11

Epistem Holdings Appoints David Budd As New Chief Executive

Read more
16 Dec 2015 14:29

DIRECTOR DEALINGS: Epistem Executives Buy 60,000 Shares

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.